UK markets open in 1 hour 44 minutes

Inozyme Pharma, Inc. (INZY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.8500+0.1200 (+2.54%)
At close: 04:00PM EDT
4.7400 -0.11 (-2.27%)
After hours: 05:47PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
34,588
32,915
23,316
28,040
-
Other short-term investments
154,001
94,951
88,485
119,657
-
Total cash
188,589
127,866
111,801
147,697
-
Total current assets
196,250
131,393
115,342
150,979
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
5,005
5,370
5,437
2,975
-
Accumulated depreciation
-2,413
-1,732
-1,001
-327
-
Net property, plant and equipment
2,592
3,638
4,436
2,648
-
Equity and other investments
-
-
0
12,199
0
Other long-term assets
311
354
354
354
-
Total non-current assets
4,597
7,802
8,199
18,384
-
Total assets
200,847
139,195
123,541
169,363
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
1,166
2,544
2,394
3,069
-
Accrued liabilities
12,610
11,355
8,508
6,625
-
Total current liabilities
14,686
14,715
11,633
9,973
-
Non-current liabilities
Long-term debt
44,769
4,139
-
-
-
Other long-term liabilities
-
124
-
-
-
Total non-current liabilities
45,682
6,086
2,640
1,287
-
Total liabilities
60,368
20,801
14,273
11,260
-
Stockholders' equity
Common stock
6
4
2
2
-
Retained earnings
-285,930
-214,761
-147,700
-91,076
-
Accumulated other comprehensive income
41
-205
18
2
-
Total stockholders' equity
140,479
118,394
109,268
158,103
-
Total liabilities and stockholders' equity
200,847
139,195
123,541
169,363
-